MedTrace Logo

A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis

NCT01905735 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-08-02

No results posted yet for this study

Summary

the purpose of the study is to assess the safety and efficacy of commonly used Homeopathic medicine Rhustoxicodendron in 30 potency in the treatment of Rheumatoid arthritis.

Conditions

  • Rheumatoid Arthritis.

Interventions

DRUG

Rhustoxicodendron 30

1/2ml Rhustoxicodendron 30 is administered orally every 7 day for 5 month.

DRUG

placebo

1/2 ml of dispensing alcohol is administered every 7 day for 5 month orally.

Sponsors & Collaborators

  • Healthcare Homoeo Charitable Society

    lead OTHER

Principal Investigators

  • ravinder kochhar, MD hom · Healthcare Homoeo Charitable Society

  • mukesh k singh, B.H.M.S · health care homoeo charitable society

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-01-31
Completion
2014-02-28

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01905735 on ClinicalTrials.gov